New Delhi: In a major development, Reliance Life Sciences has developed an RT-PCR kit that can give Covid results 2 hours.
New Delhi: In a major development,Reliance Life Sciences has developed an RT-PCR kit that can give Covid results 2 hours.
Named as R-Green Kit (SARS COV2-real-time PCR) has been technically validated by ICMR for satisfactory performance. As per ICMR results, the kit shows 98.7 per cent sensitivity and 98.8 per cent specificity.
While Covid-19 RT-PCR test, which is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2, takes up to 24 hours to give a diagnosis, the R-Green Kit promises results within 2 hours.
The kit is being devloped by computational biologists at Reliance Life Sciences, a subsidiary of billionaire Mukesh Ambani-run Reliance Industries Ltd.
The kit, developed by scientists at Reliance Life Sciences, is named R-Green.
The kit which is a complete indigenous development by the R&D scientists working at the firm,is reported to be simple to use and uses readily available simple reagents and primers which can be synthesised in India.
Reports indicate that the kit can detect the presence of E-gene, R-gene, RdRp gene of SARS COV2 virus with Actin as an internal control. However, ICMR's validation process doesn't approve/disapprove the kit design, as well as it does not certify user-friendliness.
A separate study by Reliance Life Sciences has indicated that the death rate for Covid-19 pandemic may significantly reduce by the end of 2020.
Named as R-Green Kit (SARS COV2-real-time PCR) has been technically validated by ICMR for satisfactory performance. As per ICMR results, the kit shows 98.7 per cent sensitivity and 98.8 per cent specificity.
While Covid-19 RT-PCR test, which is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2, takes up to 24 hours to give a diagnosis, the R-Green Kit promises results within 2 hours.
The kit is being devloped by computational biologists at Reliance Life Sciences, a subsidiary of billionaire Mukesh Ambani-run Reliance Industries Ltd.
The kit, developed by scientists at Reliance Life Sciences, is named R-Green.
The kit which is a complete indigenous development by the R&D scientists working at the firm,is reported to be simple to use and uses readily available simple reagents and primers which can be synthesised in India.
Reports indicate that the kit can detect the presence of E-gene, R-gene, RdRp gene of SARS COV2 virus with Actin as an internal control. However, ICMR's validation process doesn't approve/disapprove the kit design, as well as it does not certify user-friendliness.
A separate study by Reliance Life Sciences has indicated that the death rate for Covid-19 pandemic may significantly reduce by the end of 2020.